Literature DB >> 29866682

Antiphospholipid syndrome masquerading as a case of infective endocarditis.

Sarah Micallef1, Charles Mallia Azzopardi2.   

Abstract

A 54-year-old Caucasian woman presented with an episode of loss of consciousness and dysphasia. MRI revealed a number of ischaemic foci indicating an embolic source. Echocardiography showed a mitral valve vegetation. After taking three sets of blood cultures, she was started on empirical treatment for infective endocarditis. The blood cultures remained negative and a presumed diagnosis of culture-negative endocarditis was entertained. However, despite the antibiotic therapy, the patient deteriorated further. Subsequently the patient was found to be positive for antiphospholipid antibodies. Eventually, after a convoluted hospital stay, a diagnosis of antiphospholipid syndrome complicated by Libman-Sacks endocarditis was reached. The patient was treated with steroids and anticoagulation with dramatic improvement. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  connective tissue disease; immunology; stroke; vasculitis

Mesh:

Substances:

Year:  2018        PMID: 29866682      PMCID: PMC5990064          DOI: 10.1136/bcr-2018-224404

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Treatment of catastrophic antiphospholipid syndrome.

Authors:  Nayef M Kazzaz; W Joseph McCune; Jason S Knight
Journal:  Curr Opin Rheumatol       Date:  2016-05       Impact factor: 5.006

2.  14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.

Authors:  Ricard Cervera; Ignasi Rodríguez-Pintó; Serena Colafrancesco; Fabrizio Conti; Guido Valesini; Cristina Rosário; Nancy Agmon-Levin; Yehuda Shoenfeld; Claudia Ferrão; Raquel Faria; Carlos Vasconcelos; Flavio Signorelli; Gerard Espinosa
Journal:  Autoimmun Rev       Date:  2014-03-20       Impact factor: 9.754

3.  Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Ann F Bolger; Matthew E Levison; Patricia Ferrieri; Michael A Gerber; Lloyd Y Tani; Michael H Gewitz; David C Tong; James M Steckelberg; Robert S Baltimore; Stanford T Shulman; Jane C Burns; Donald A Falace; Jane W Newburger; Thomas J Pallasch; Masato Takahashi; Kathryn A Taubert
Journal:  Circulation       Date:  2005-06-14       Impact factor: 29.690

4.  Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients.

Authors:  Silvia Bucciarelli; Gerard Espinosa; Ricard Cervera; Doruk Erkan; José A Gómez-Puerta; Manuel Ramos-Casals; Josep Font; Ronald A Asherson
Journal:  Arthritis Rheum       Date:  2006-08

5.  Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".

Authors:  Ricard Cervera; Silvia Bucciarelli; Miguel A Plasín; José A Gómez-Puerta; Joan Plaza; Guillermo Pons-Estel; Yehuda Shoenfeld; Miguel Ingelmo; Gerard Espinos
Journal:  J Autoimmun       Date:  2009-03-26       Impact factor: 7.094

Review 6.  Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome.

Authors:  M Hojnik; J George; L Ziporen; Y Shoenfeld
Journal:  Circulation       Date:  1996-04-15       Impact factor: 29.690

7.  Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution.

Authors:  Ioannis Moyssakis; Maria G Tektonidou; Vassilios A Vasilliou; Michael Samarkos; Vassilios Votteas; Haralampos M Moutsopoulos
Journal:  Am J Med       Date:  2007-07       Impact factor: 4.965

Review 8.  Pathophysiology of the antiphospholipid antibody syndrome.

Authors:  Rohan Willis; Silvia S Pierangeli
Journal:  Auto Immun Highlights       Date:  2011-03-24

Review 9.  Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.

Authors:  Cecilia Beatrice Chighizola; Tania Ubiali; Pier Luigi Meroni
Journal:  J Immunol Res       Date:  2015-05-05       Impact factor: 4.818

  9 in total
  1 in total

1.  Improvement of Cardiac Vegetations in Antiphospholipid Syndrome with Enoxaparin and Corticosteroids after Rivaroxaban Failure.

Authors:  Eric Granowicz; Kiyon Chung
Journal:  Case Rep Hematol       Date:  2018-09-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.